Magnetic resonance techniques in multiple sclerosis: The present and the future

Archives of Neurology

Volumn 68, Issue 12, 2011, Pages 1514-1520

  Filippi, Massimo ^a   Rocca, Maria A ^a   De Stefano, Nicola ^b   Enzinger, Christian ^c   Fisher, Elizabeth ^d   Horsfield, Mark A ^e   Inglese, Matilde ^f   Pelletier, Daniel ^g   Comi, Giancarlo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; IRON; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BRAIN ATROPHY; BRAIN PERFUSION; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IRON STORAGE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER;

EID: 83455225223     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.914     Document Type: Review

References (46)

1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292- 302.
2. Simon JH, Li D, Traboulsee A, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol. 2006;27(2):455-461. (Pubitemid 44897861)
3. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157-1174.
4. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation." Lancet Neurol. 2006; 5(10):841-852. (Pubitemid 44715819)
5. Fazekas F, Soelberg-Sorensen P, Comi G, Filippi M. MRI to monitor treatment efficacy in multiple sclerosis. J Neuroimaging. 2007;17(suppl 1):50S-55S. (Pubitemid 46558270)
6. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998;50(5):1282-1288. (Pubitemid 28240340)
7. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol. 1998;19 (4):675-683. (Pubitemid 30422711)
8. Simon JH. Brain atrophy in multiple sclerosis: what we know and would like to know. Mult Scler. 2006;12(6):679-687. (Pubitemid 46111759)
9. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. 2002;125(pt 8):1676-1695.
10. De Stefano N, Giorgio A, Battaglini M, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology. 2010; 74(23):1868-1876.
11. Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol. 2008;64(3):247-254.
12. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008;64(3):255-265.
13. Lycklama G, Thompson A, Filippi M, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2003;2(9):555-562. (Pubitemid 36994995)
14. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009;5(5): 256-266.
15. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion- recovery MR imaging. Radiology. 2005;236(1):254-260. (Pubitemid 40853320)
16. Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nat Rev Neurol. 2010;6(8):438-444.
17. Filippi M, Rocca MA, Calabrese M, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75(22):1988- 1994.
18. Roosendaal SD, Moraal B, Vrenken H, et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging. 2008;27(4):726-731. (Pubitemid 351508085)
19. Pouwels PJ, Kuijer JP, Mugler JP III, Guttmann CR, Barkhof F. Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatialresolution MR imaging. Radiology. 2006;241(3):873-879. (Pubitemid 46190555)
20. Nelson F, Poonawalla A, Hou P, Wolinsky JS, Narayana PA. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler. 2008; 14(9):1214-1219.
21. Geurts JJ, Roosendaal SD, Calabrese M, et al. MAGNIMS Study Group. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology. 2011;76(5):418-424.
22. Filippi M, Rocca MA. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics. 2007;4(3):401-413. (Pubitemid 46962400)
23. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol. 2004; 56(3):407-415. (Pubitemid 39166560)
24. Inglese M, van Waesberghe JH, Rovaris M, et al. The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS. Neurology. 2003;60(5):853-860. (Pubitemid 36297373)
25. Filippi M, Rocca MA, Pagani E, et al. European Study on Intravenous Immunoglobulin in Multiple Sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch Neurol. 2004;61(9):1409-1412. (Pubitemid 39202224)
26. Ropele S, Filippi M, Valsasina P, et al. Assessment and correction of B1-induced errors in magnetization transfer ratio measurements. Magn Reson Med. 2005; 53(1):134-140. (Pubitemid 40110486)
27. Rovaris M, Agosta F, Pagani E, Filippi M. Diffusion tensor MR imaging. Neuroimaging Clin N Am. 2009;19(1):37-43.
28. Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage. 2007;35(2):467-477. (Pubitemid 46400551)
29. De Stefano N, Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging. 2007;17(suppl 1):31S-35S. (Pubitemid 46558266)
30. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007;69(20):1942- 1952. (Pubitemid 350100353)
31. Sajja BR, Narayana PA, Wolinsky JS, Ahn CW; PROMISE Trial MRSI Group. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study. Mult Scler. 2008;14(1):73-80. (Pubitemid 351541399)
32. Horsfield MA, Barker GJ, Barkhof F, Miller DH, Thompson AJ, Filippi M. Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Reson Imaging. 2003; 17(4):389-397. (Pubitemid 36396940)
33. Pagani E, Bammer R, Horsfield MA, et al. Diffusion MR imaging in multiple sclerosis: technical aspects and challenges. AJNR Am J Neuroradiol. 2007;28(3): 411-420. (Pubitemid 46486632)
34. Filippi M, Rocca MA. Functional MR imaging in multiple sclerosis. Neuroimaging Clin N Am. 2009;19(1):59-70.
35. Valsasina P, Agosta F, Absinta M, Sala S, Caputo D, Filippi M. Cervical cord functional MRI changes in relapse-onset MS patients. J Neurol Neurosurg Psychiatry. 2010;81(4):405-408.
36. Rocca MA, Absinta M, Moiola L, et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology. 2010;254(2):541-550.
37. Wegner C, Filippi M, Korteweg T, et al. Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multicentre fMRI study. Eur J Neurol. 2008;15(2):113-122.
38. Dousset V, Brochet B, Deloire MS, et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol. 2006;27(5):1000-1005. (Pubitemid 44897675)
39. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol. 2008;7(7):615-625.
40. Ge Y, Law M, Johnson G, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol. 2005;26(6):1539-1547. (Pubitemid 43733458)
41. Adhya S, Johnson G, Herbert J, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage. 2006;33(4):1029-1035. (Pubitemid 44708796)
42. Rashid W, Parkes LM, Ingle GT, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75(9):1288-1293. (Pubitemid 39141335)
43. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007;4(3):371-386. (Pubitemid 46962416)
44. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 tesla with sensitivity to iron. Ann Neurol. 2008;64(6):707-713.
45. Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009;73(12):941- 948.
46. Srinivasan R, Ratiney H, Hammond-Rosenbluth KE, Pelletier D, Nelson SJ. MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. Magn Reson Imaging. 2010;28(2):163-170.